The article discusses possible developments in gene therapy during the 50 years following 2013. Topics include the fictitious approval of gene therapy treatments by the U.S. Food and Drug Administration in 2014, treatments for blindness and spinal cord injuries, and the use of gene therapy to predict developments in the health of patients.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados